A novel pro-inflammatory mechanism of action of resistin in human endothelial cells: Up-regulation of SOCS3 expression through STAT3 activation

Biochemical and Biophysical Research Communications

Volumn 422, Issue 2, 2012, Pages 321-326

  Pirvulescu, Monica ^a   Manduteanu, Ileana ^a   Gan, Ana Maria ^a   Stan, Daniela ^a   Simion, Viorel ^a   Butoi, Elena ^a   Calin, Manuela ^a,b   Simionescu, Maya ^a  

^a INSTITUTE OF CELLULAR BIOLOGY AND PATHOLOGY NICOLAE SIMIONESCU   (Romania)

^b PETRU PONI INSTITUTE OF MACROMOLECULAR CHEMISTRY   (Romania)

Author keywords

Human endothelial cells; Resistin; Signal transducers and activators of transcription; Suppressor of cytokine signaling 3

Indexed keywords

FRACTALKINE; PADGEM PROTEIN; RESISTIN; SMALL INTERFERING RNA; STAT3 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 3;

ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOKINE RESPONSE; ENDOTHELIUM CELL; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; INFLAMMATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION;

ENDOTHELIAL CELLS; HUMANS; INFLAMMATION; RESISTIN; STAT3 TRANSCRIPTION FACTOR; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; TRANSCRIPTIONAL ACTIVATION; UP-REGULATION;

MUS;

EID: 84861694184     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.04.159     Document Type: Article

References (17)

1. Boström E.A., Tarkowski A., Bokarewa M. Resistin is stored in neutrophil granules being released upon challenge with inflammatory stimuli. Biochim. Biophys. Acta. 2009, 1793:1894-1900.
2. Reilly M.P., Lehrke M., Wolfe M.L., et al. Resistin is an inflammatory marker of atherosclerosis in humans. Circulation 2005, 111:932-939.
3. Kawanami D., Maemura K., Takeda N., et al. Direct reciprocal effects of resistin and adiponectin on vascular endothelial cells: a new insight into adipocytokine-endothelial cell interactions. Biochem. Biophys. Res. Commun. 2004, 314:415-419.
4. Verma S., Li S.-H., Wang C.-H., et al. Resistin promotes endothelial cell activation: further evidence of adipokine-endothelial interaction. Circulation 2003, 108:736-740.
5. Manduteanu I., Dragomir E., Calin M., et al. Resistin up-regulates fractalkine expression in human endothelial cells: lack of additive effect with TNF-alpha. Biochem. Biophys. Res. Commun. 2009, 381:96-101.
6. Manduteanu I., Pirvulescu M., Gan A.M., et al. Similar effects of resistin and high glucose on P-selectin and fractalkine expression and monocyte adhesion in human endothelial cells. Biochem. Biophys. Res. Commun. 2010, 391:1443-1448.
7. Bjørbaek C., El-Haschimi K., Frantz J.D., Flier J.S. The role of SOCS-3 in leptin signaling and leptin resistance. J. Biol. Chem. 1999, 274:30059-30065.
8. O'Sullivan L.A., Liongue C., Lewis R.S., et al. Cytokine receptor signaling through the Jak-Stat-Socs pathway in disease. Mol. Immunol. 2007, 44:2497-2506.
9. Steppan C.M., Wang J., Whiteman E.L., et al. Activation of SOCS-3 by Resistin. Mol. Cell Biol. 2005, 25:1569-1575.
10. Jung H.S., Park K., Cho S., Park K., et al. Resistin is secreted from macrophages in atheromas and promotes atherosclerosis. Cardiovasc. Res. 2006, 69:76-85.
11. Croker B.A., Krebs D.L., Zhang J.-G., et al. SOCS3 negatively regulates IL-6 signaling in vivo. Nat. Immunol. 2003, 4:540-545.
12. Bluyssen H.A.R., Rastmanesh M.M., Tilburgs C., et al. IFN-dependent SOCS3 expression inhibits IL-6-induced STAT3 phosphorylation and differentially affects IL-6 mediated transcriptional responses in endothelial cells. AJP: Cell Physiol. 2010, 299:C354-C362.
13. Cho Y., Lee S.E., Lee H.C., et al. Adipokine resistin is a key player to modulate monocytes, endothelial cells, and smooth muscle cells, leading to progression of atherosclerosis in rabbit carotid artery. J. Am. Coll. Cardiol. 2011, 57:99-109.
14. Ortiz-Munoz G., Martin-Ventura J.L., Hernandez-Vargas P., et al. Suppressors of cytokine signaling modulate JAK/STAT-mediated cell responses during atherosclerosis. Arterioscler., Thromb., Vasc. Biol. 2009, 29:525-531.
15. Tarkowski A., Bjersing J., Shestakov A., Bokarewa M.I. Resistin competes with lipopolysaccharide for binding to toll-like receptor 4. J. Cell Mol. Med. 2010, 14:1419-1431.
16. Liu K., Liang C., Liang Z., Tus K., Wakeland E.K. Sle1ab mediates the aberrant activation of STAT3 and Ras-ERK signaling pathways in B lymphocytes. J. Immunol. 2005, 174:1630-1637.
17. Migita K., Maeda Y., Miyashita T., et al. The serum levels of resistin in rheumatoid arthritis patients. Clin. Exp. Rheumatol. 2006, 24:698-701.